Tolmetin Sodium

托美丁钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTolmetin Sodium
Drug Alias Nametolmetina托尔米丁Tolmetinum托耳米丁托麦汀钠 +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsOsteoarthritisArthritis, RheumatoidArthritis, Juvenile
Global Approved IndicationsOsteoarthritisArthritis, Rheumatoid
Approved Indications in ChinaArthritis, Rheumatoid
Original Approved Country/TerritoryUnited States
Original Approved Date1976/03/24
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active IndicationsArthritis, Rheumatoid
Inactive IndicationsOsteoarthritisArthritis, Juvenile

Other Information

ATC CodeM01AB03M02AA21